# Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine

> **NCT00258817** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 30 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza Virus Vaccine (Fluzone®)
- **BIOLOGICAL:** Influenza Virus Vaccine (Fluzone®)

## Key facts

- **NCT ID:** NCT00258817
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-03
- **Final completion:** 2007-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00258817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00258817, "Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00258817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*